Based on our advanced algorithm, we predict that BTAI stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $1.83, while the 1-week outlook suggests a value of $1.85. For the 1-month forecast, we project a price of $1.8. Looking further ahead, our 2026 projection estimates a value of $0.85, with a long-term 2030 forecast reaching $0.17. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BTAI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
BTAI stock price ended at $1.7 on Monday, after losing-6.08%
The BioXcel Therapeutics Inc stock price decreased by -6.08% on the last trading day (28 Jul 2025), dropping from 1.8 to 1.7. Throughout the last trading session, the stock experienced a fluctuation of 10.28% , ranging from a day low of $1.65 to a day high of 1.8196. The price has declined in 7 of the last 10 days, resulting in a total change of -15.84% during this period. On the last day, trading volume increase by 143.09K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 356.96K shares were traded, amounting to approximately 611.36K.
BTAI Technical Signals
BTAI(BioXcel Therapeutics Inc Corp) has 4 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-07-16. The total price change during this trend is -12.82%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of BTAI over the last 5 trading days is 586.60K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
BTAI Moving Average Analysis
BioXcel Therapeutics Inc's overall moving average trend leans more bearish as of Tuesday, July 29, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $2.30, and $2.54. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.54, and $1.30. A break-down below any of these levels will issue sell signals.
BTAI Short Selling Analysis
The short sale ratio of BioXcel Therapeutics Inc(BTAI) as of 25 Jul 2025 is 24.77%, rising from last trading day. With increasing price from 1.73 to 1.81. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
11.384
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-160.454
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
10.193
Bullish
Williams %R (14 days)
WILLR_14 < -80
-91.935
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, BioXcel Therapeutics Inc (BTAI) is anticipated to change hands in a trading channel between $0.57 and $1.07.
BioXcel Therapeutics Inc Stock Forecast 2026
Jan 2026: BTAI Stock Forecast
Potential ROI: -56.17%
In Jan 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.90. The price is predicted to fluctuate between a low of $0.75 and a high of $0.97.
Feb 2026: BTAI Stock Forecast
Potential ROI: -53.15%
In Feb 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.96. The price is predicted to fluctuate between a low of $0.90 and a high of $0.97.
Mar 2026: BTAI Stock Forecast
Potential ROI: -53.15%
In Mar 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.96. The price is predicted to fluctuate between a low of $0.84 and a high of $1.07.
Apr 2026: BTAI Stock Forecast
Potential ROI: -58.01%
In Apr 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.86. The price is predicted to fluctuate between a low of $0.69 and a high of $0.95.
May 2026: BTAI Stock Forecast
Potential ROI: -53.15%
In May 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.96. The price is predicted to fluctuate between a low of $0.92 and a high of $1.05.
Jun 2026: BTAI Stock Forecast
Potential ROI: -53.15%
In Jun 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.96. The price is predicted to fluctuate between a low of $0.96 and a high of $0.98.
Jul 2026: BTAI Stock Forecast
Potential ROI: -58.59%
In Jul 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.85. The price is predicted to fluctuate between a low of $0.70 and a high of $0.86.
Aug 2026: BTAI Stock Forecast
Potential ROI: -59.26%
In Aug 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.84. The price is predicted to fluctuate between a low of $0.71 and a high of $0.90.
Sep 2026: BTAI Stock Forecast
Potential ROI: -62.49%
In Sep 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.77. The price is predicted to fluctuate between a low of $0.66 and a high of $0.85.
Oct 2026: BTAI Stock Forecast
Potential ROI: -65.03%
In Oct 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.72. The price is predicted to fluctuate between a low of $0.57 and a high of $0.74.
Nov 2026: BTAI Stock Forecast
Potential ROI: -54.33%
In Nov 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.92 and a high of $0.95.
Dec 2026: BTAI Stock Forecast
Potential ROI: -58.03%
In Dec 2026, BioXcel Therapeutics Inc's value is forecasted to reach an average price of $0.86. The price is predicted to fluctuate between a low of $0.70 and a high of $0.94.
BTAI Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to BioXcel Therapeutics Inc(BTAI), our algorithm predicts BTAI's 1-month price at $1.93, with an 6.77%upwardshift. Using a similarity score up to 93.42%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for BioXcel Therapeutics Inc (BTAI.O) stock, as of Sunday, July 27, 2025 , forecasts a 6.77% change over the next month, based on its high correlation with LFCR.O stock patterns. The similarity between their price movements over the analyzed periods is 93.42%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
BTAI
Future prediction
Up: 6.77%
LFCR
Up: 6.77%Similarity: 93.42%
Name
Similarity
Up/Down
LFCR.O
93.42%
+6.77%
BG.N
91.77%
-3.78%
PLUG.O
91.00%
-5.13%
AGYS.O
90.83%
+19.85%
EMCG.O
90.64%
+0.36%
ARTNA.O
90.52%
+1.75%
IDXX.O
90.31%
-8.34%
CMCM.N
90.25%
-32.40%
DRS.O
90.08%
-18.46%
FLYW.O
90.07%
-12.57%
BTAI Seasonality Analysis
Based on BTAI's historical stock price data across all years, the probability of a positive return in July is50.00%, suggesting it maybe an ideal month to invest in BTAI. In contrast,Februaryoffers the highest probability of positive returns at71.43%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying BioXcel Therapeutics Inc (BTAI.O) stock in February has the highest probability of a positive return (71.43%), while August has the lowest probability (14.29%).
Performance Seasonality
The chart shows BioXcel Therapeutics Inc. (BTAI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy BioXcel Therapeutics Inc (BTAI.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. BTAI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying BioXcel Therapeutics Inc (BTAI.O) stock in a year?
The radar chart shows that buying BioXcel Therapeutics Inc (BTAI.O) stock in February has the highest probability of a positive return (71.43%), while August has the lowest probability (14.29%).
How has BioXcel Therapeutics Inc. (BTAI)'s stock price performed over the past three years?
BTAI's stock price fell by -86.25% in 2023,decreased by -87.24% in 2024, and went down by 72.9%in 2025.
Is BTAI a buy based on overall technical signals summary?
BTAI has 4 buy signals and 4 sell signals now. Overall the technical rating for BTAI is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of BTAI.
What is the trend of BioXcel Therapeutics Inc (BTAI)'s moving average?
BioXcel Therapeutics Inc's overall moving average trend leans more bearish as of July 29 2025, with 3 negative signals and 1 positive signal.
What is price prediction for BTAI stock next month?
The price prediction chart for BioXcel Therapeutics Inc (BTAI.O) stock, as of July 27 2025, forecasts a 6.77% change over the next month, based on its high correlation with LFCR stock patterns. The similarity between their price movements over the analyzed periods is 93.42%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for BTAI Stock?
### **Price Prediction for BTAI Stock in 2025**
Based on the analysis of technical indicators and recent news, here is the price prediction for BTAI stock in 2025:
1. **Short-Term Prediction**: BTAI stock is expected to reach **$5.00** by the end of 2025, driven by positive FDA developments and progress in clinical trials for BXCL501.
2. **Mid-Term Prediction**: The stock has the potential to reach **$7.00** if the company successfully advances its pipeline and receives favorable regulatory outcomes.
3. **Long-Term Prediction**: Considering the company's strong pipeline and AI-driven drug development approach, BTAI could reach **$10.00** in the next 2-3 years.
**Reasons for the Prediction**:
- Recent FDA inspection results and favorable feedback on the TRANQUILITY II trial.
- Strong analyst sentiment and average price target of $5.00.
- Growing demand for AI-driven drug discovery solutions.
What is price prediction 2030 for BTAI Stock?
### **Price Prediction for BTAI Stock in 2030**
BTAI stock is expected to reach **$15 by 2030**, driven by its strong pipeline in AI-enabled neuroscience treatments and recent positive FDA developments. The stock's current bullish technical indicators, including high RSI and Stochastic levels, support continued upward momentum.